Targeting RNA modifications to change breast cancer behavior
Disrupting long noncoding RNA methylation to elicit antimorph behavior in breast cancer
['FUNDING_R21'] · UNIVERSITY OF COLORADO DENVER · NIH-10818526
This study is looking at how changing certain tiny parts of RNA in breast cancer can help turn them from promoting cancer to fighting it, which could lead to new treatments that help patients like you.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF COLORADO DENVER (nih funded) |
| Locations | 1 site (Aurora, UNITED STATES) |
| Trial ID | NIH-10818526 on ClinicalTrials.gov |
What this research studies
This research investigates how specific long noncoding RNAs (LncRNAs) in breast cancer can be modified to switch their role from promoting cancer to suppressing it. By focusing on a single nucleotide mutation that prevents RNA methylation, the study aims to enhance the expression of a converted LncRNA that can reduce cancer characteristics more effectively than simply removing the cancer-promoting RNA. The researchers will explore this novel therapeutic approach to disrupt the m6A methylation pathway, potentially leading to new treatments for breast cancer. Patients may benefit from insights that could translate into innovative therapies targeting these RNA modifications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with breast cancer, particularly those with specific LncRNA profiles.
Not a fit: Patients with non-breast cancer malignancies or those whose cancer does not involve the targeted LncRNAs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment strategies that effectively reduce breast cancer progression by modifying RNA behavior.
How similar studies have performed: While the approach of targeting RNA modifications is relatively novel, preliminary findings suggest that similar strategies have shown promise in other cancer types.
Where this research is happening
Aurora, UNITED STATES
- UNIVERSITY OF COLORADO DENVER — Aurora, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: JOHNSON, AARON M. — UNIVERSITY OF COLORADO DENVER
- Study coordinator: JOHNSON, AARON M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Breast Cancer, Cancers, neoplasm/cancer